Education

Ph.D. in Molecular Cell Biology, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland, 2013

Current position

Post-doctoral Fellow at Department of Blood Cell Research, Sanquin Blood Bank, Amsterdam, The Netherlands

Publications (since 2005)

1. Scheenstra, M. R., Salunkhe, V., De Cuyper, I. M., Hoogenboezem, M., Li, E., Kuijpers, T. W., van den Berg, T. K. and Gutierrez, L. (2015). Characterization of hematopoietic GATA transcription factor expression in mouse and human dendritic cells. Blood Cells Mol Dis 55(4): 293-303.
   
2. Salunkhe, V., van der Meer, P. F., de Korte, D., Seghatchian, J. and Gutierrez, L. (2015). Development of blood transfusion product pathogen reduction treatments: a review of methods, current applications and demands. Transfus Apher Sci 52(1): 19-34.
   
3. Macaulay, I. C., Thon, J. N., Tijssen, M. R., Steele, B. M., MacDonald, B. T., Meade, G., Burns, P., Rendon, A., Salunkhe, V., Murphy, R. P., Bennett, C., Watkins, N. A., He, X., Fitzgerald, D. J., Italiano, J. E., Jr. and Maguire, P. B. (2013). Canonical Wnt signaling in megakaryocytes regulates proplatelet formation. Blood 121(1): 188-196.
   
4. Pchejetski, D., Boehler, T., Brizuela, L., Sauer, L., Doumerc, N., Golzio, M., Salunkhe, V., Tessie, J., Malavaud, B., Waxman, J., Cuvillier, O. (2010). Immunosuppressive drug FTY720 sensitizes Prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1. Cancer res 70(21):8651-61.
   
5. Sauer, L., Nunes, J., Salunkhe, V., Skalska, L., Kohama, T., Cuvillier, O., Waxman, J. and Pchejetski, D. (2009). Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel. Int J Cancer 125(11): 2728-2736.
   
6. Pchejetski, D., Sauer, L., Nunes, J., Salunkhe, V., Kohama, T., Cuvillier, O. and Waxman, J. (2009). Sphingosine kinase 1 inhibition sensitizes hormone‐resistant prostate and breast cancer cells to docetaxel. EJC Suppl 7(2):107‐107.